Relapsed or Refractory Primary Mediastinal B-cell Lymphoma (rrPMBCL)
1 clinical trials · Condition
◉ Watch Relapsed or Refractory Primary Mediastinal B-cell Lymphoma (rrPMBCL)
| Record | Firm | Date |
|---|---|---|
| Study of TQB2450 Injection in Subjects With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (NCT04002622) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2019-08-06 |
Track Relapsed or Refractory Primary Mediastinal B-cell Lymphoma (rrPMBCL) automatically
Every clearance here is in the API, with alerts when new ones post.